At Heron Therapeutics, our mission is to improve the lives of patents by developing innovative treatments that address important unmet patient needs. Our portfolio includes CINVANTI® (aprepitant) injectable emulsion and SUSTOL® (granisetron) extended-release injection.
Brands: https://events.jspargo.com/ASCO21/CUSTOM/ASCO%20Virtual%20Booth%20assests%20banner%20heron1140X250.jpg
Show Specials
Press Releases
Products